Not even worth wearing out my phone keyboard to respond to his comments. As u know I am usually receptive of critical comments on the stock (and I have delivered a few myself), but his comments reflects total lack of underestanding of research, biotech, health sector, drug development, registration, distribution and marketing in general. Had he been a tad more humble in his presentation, I and others would have responded & he could have learnt something ... but seems, he does not need learning.
Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO, page-72
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.8¢ | $684.8K | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 436502 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 92443 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |